Why the study?
Right ventricular involvement is a potential high-risk marker in HCM, but its prognostic relevance in apical HCM remains unclear.
Does right ventricular involvement increase the risk of cardiovascular events in patients with apical hypertrophic cardiomyopathy?
Does right ventricular involvement increase the risk of cardiovascular events in patients with apical hypertrophic cardiomyopathy?
Right ventricular involvement and specific imaging-derived phenotypes identify patients with apical hypertrophic cardiomyopathy at significantly higher risk for cardiovascular events.
RV phenotyping may refine apical HCM risk stratification; leaves open need for prospective validation before practice change.
BACKGROUND: Right ventricular (RV) involvement is a potential high-risk marker in hypertrophic cardiomyopathy (HCM); however, its prognostic relevance in apical HCM remains unclear. OBJECTIVES: This study aimed to evaluate the prognostic significance of RV involvement in apical HCM and the incremental value of imaging-based phenotyping. METHODS: We retrospectively analyzed 289 patients with apical HCM who underwent cardiovascular magnetic resonance and strain echocardiography. Patients were classified into 3 morphological subtypes-purely apical, mixed, and RV involvement. The primary outcome was a composite of cardiovascular (CV) events. RESULTS: In total, 117 patients (40.5%) had purely apical HCM, 102 (35.3%) had mixed apical HCM, and 70 (24.2%) had RV involvement. During a median follow-up of 7.7 years, 35 (12.1%) patients experienced CV events. RV involvement was associated with a higher risk of CV events (adjusted HR: 2.59; 95% CI: 1.02-6.60; P = 0.046). Imaging-based clustering identified 2 distinct phenotypic subgroups: Cluster 1 (n = 200) and cluster 2 (n = 89). Cluster 2 was characterized by greater hypertrophy, more fibrosis, and impaired systolic/diastolic function, and was associated with a higher risk of CV events (adjusted HR: 2.31; 95% CI: 1.04-5.13; P = 0.039). When stratified into 4 groups according to cluster and RV involvement, patients in cluster 2 with RV involvement exhibited the highest risk (adjusted HR: 4.02; 95% CI: 1.44-11.19; P = 0.008). CONCLUSIONS: RV involvement is associated with adverse prognosis in apical HCM, and imaging-based clustering further identifies high-risk phenotypes. Combined risk stratification incorporating imaging-derived clusters and RV morphology may enhance individualized risk assessment in this population.
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: